Tylenol vs Oracle Health

Side-by-side comparison of AI visibility scores, market position, and capabilities

Oracle Health leads in AI visibility (95 vs 73)
Tylenol logo

Tylenol

LeaderHealthcare

General

Global #1 OTC acetaminophen brand owned by Kenvue (NYSE: KVUE, J&J 2023 spinoff at $41B); Kimberly-Clark $48.7B Kenvue acquisition pending close H2 2026 competing with Advil and store brand for OTC pain relief market.

AI VisibilityBeta
Overall Score
B73
Category Rank
#83 of 1158
AI Consensus
56%
Trend
stable
Per Platform
ChatGPT
69
Perplexity
64
Gemini
83

About

Tylenol is a global over-the-counter acetaminophen (paracetamol) pain relief and fever reducer brand — owned by Kenvue (NYSE: KVUE), the consumer health company spun off from Johnson & Johnson in May 2023 at a $41 billion IPO valuation, and subject to a pending $48.7 billion acquisition by Kimberly-Clark announced in November 2025 (expected to close second half 2026) — providing consumers with the world's most widely used analgesic through product lines including Tylenol Extra Strength, Tylenol PM, Tylenol Rapid Release Gels, Tylenol Children's, and Tylenol Arthritis Pain for adults and pediatric pain and fever management. Generating approximately $2 billion in annual retail sales as one of Kenvue's flagship brands alongside Neutrogena, Band-Aid, Listerine, and Zyrtec, Tylenol is the #1 recommended pain reliever by doctors and pharmacists in the United States. Originally marketed by McNeil Laboratories (acquired by J&J in 1959), the brand was approved for OTC sale in 1960.

Full profile
Oracle Health logo

Oracle Health

LeaderHealthcare

EHR Systems

Oracle Corporation's healthcare IT division (rebranded Cerner, $28.3B acquisition 2022); #2 US hospital EHR, VA/DoD federal EHR program, OCI cloud migration + ambient clinical AI competing with Epic Systems.

AI VisibilityBeta
Overall Score
A95
Category Rank
#2 of 5
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
99
Gemini
99

About

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, revenue cycle management, and population health analytics to hospitals, health systems, physician practices, ambulatory clinics, and government health agencies globally — operating as the rebranded Cerner Corporation following Oracle's $28.3 billion acquisition of Cerner in June 2022, the largest acquisition in Oracle's history. Oracle Health's EHR platform (the Cerner Millennium clinical information system) powers clinical documentation, physician order entry, nursing workflows, medication administration, and patient care coordination for approximately 30% of US hospitals — making Oracle Health the second-largest EHR vendor in the US hospital market after Epic Systems. A major integration program is underway to migrate Cerner's clinical applications to Oracle Cloud Infrastructure (OCI), enabling Oracle Health to leverage Oracle's cloud scale, Oracle's AI capabilities (generative AI for clinical documentation, ambient listening for physician notes), and Oracle's database performance advantages for health record analytics. Oracle Corporation named Clay Magouyrk and Mike Sicilia as co-CEOs in 2025 (replacing Safra Catz), positioning Oracle Health's clinical platform to benefit from the next-generation Oracle leadership team's emphasis on cloud and AI transformation.

Full profile

AI Visibility Head-to-Head

73
Overall Score
95
#83
Category Rank
#2
56
AI Consensus
86
stable
Trend
stable
69
ChatGPT
94
64
Perplexity
99
83
Gemini
99
75
Claude
99
77
Grok
99

Key Details

Category
General
EHR Systems
Tier
Leader
Leader
Entity Type
product
product

Capabilities & Ecosystem

Capabilities

Only Oracle Health
EHR Systems
Tylenol is classified as product (part of Kenvue). Oracle Health is classified as product (part of Oracle).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.